Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer
Nadia Øgaard(Aarhus University Hospital), Claus L. Andersen(Aarhus University), Lene Hjerrild Iversen(Aarhus University Hospital), Claudia Jaensch(Regionshospitalet Herning), Christina Demuth(Aarhus University Hospital), Jakob Benedict Seidelin(University of Copenhagen), Tenna Vesterman Henriksen(Aarhus University), Lars Nannestad Jørgensen(University of Copenhagen), Sarah Østrup Jensen(Aarhus University Hospital), Mai‐Britt W. Ørntoft(Aarhus University Hospital), Marijana Nesic(Aarhus University Hospital), Mads H. Rasmussen(Aarhus University), Uffe S. Løve(Regionshospitalet Viborg), Nis H. Schlesinger(Bispebjerg Hospital), Alessio Monti(North Denmark Region), Thomas Kolbro(Odense University Hospital), Jesper B. Bramsen(Goethe University Frankfurt), Amanda Frydendahl(Aarhus University), Berit Andersen(Aarhus University), Jakob Kleif(Copenhagen University Hospital), Mikail Gögenur(Zealand University Hospital Køge), Ismail Gögenür(University of Copenhagen), Jeppe Kildsig(Herlev Hospital), Christina Therkildsen(Hvidovre Hospital), Ole Thorlacius‐Ussing(Aalborg University), Jesper Nors(Aarhus University), Peter Bondeven(Regional Hospital Randers), Jesper Vilandt(Nordsjællands Hospital), Morten Rasmussen(Aarhus University), Iben Lyskjær(Aarhus University), Kåre Anderson Gotschalck(Aarhus University), Per Vadgaard Andersen(Odense University Hospital)
Cited by 10
Related Papers
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
|British Journal of Cancer|2020|1.7k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k